Skip Navigation


Carcinogenesis Advance Access originally published online on March 29, 2006
Carcinogenesis 2006 27(7):1497-1501; doi:10.1093/carcin/bgl019
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
27/7/1497    most recent
bgl019v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Jakszyn, P.
Right arrow Articles by Gonzalez, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jakszyn, P.
Right arrow Articles by Gonzalez, C. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Endogenous versus exogenous exposure to N-nitroso compounds and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST) study

Paula Jakszyn *, Sheila Bingham 1, Guillem Pera, Antonio Agudo, Robert Luben 2, Ailsa Welch 2, Heiner Boeing 3, Giuseppe del Giudice 4, Domenico Palli 5, Calogero Saieva 5, Vittorio Krogh 6, Carlotta Sacerdote 7, Rosario Tumino 8, Salvatore Panico 9, Göran Berglund 10, Henrik Simán 10, Göran Hallmans 11, María José Sanchez 12, Nerea Larrañaga 13, Aurelio Barricarte 14, María Dolores Chirlaque 15, José R. Quirós 16, Timothy J. Key 17, Naomi Allen 17, Eiliv Lund 18, Fátima Carneiro 19, Jakob Linseisen 20, Gabriele Nagel 20, Kim Overvad 21, Anne Tjonneland 22, Anja Olsen 22, H. Bas Bueno-de-Mesquita 23, Marga O. Ocké 23, Petra HM. Peeters 24, Mattijs E. Numans 24, Françoise Clavel-Chapelon 25, Antonia Trichopoulou 26, Claus Fenger 27, Roger Stenling 28, Pietro Ferrari 29, Mazda Jenab 29, Teresa Norat 29, Elio Riboli 29, 30 and Carlos A. Gonzalez

Department of Epidemiology, Catalan Institute of Oncology, (ICO-IDIBELL) Barcelona, Spain, 1 Medical Research Council, Dunn Human Nutrition Unit, Wellcome Trust/MRC Building, Cambridge, UK, 2 Strangeways Research Laboratory, Cambridge, UK, 3 German Institute of Human Nutrition, Potsdam-Rehbücke, Germany, 4 IRIS Research Center, Chiron-Vaccines, Siena, Italy, 5 Molecular and Nutritional Epidemiology Unit, CSPO – Scientific Institute of Tuscany, Florence, Italy, 6 Epidemiology Unit, Istituto Tumori, Milan, Italy, 7 University of Torino, Italy, 8 Cancer Registry, Azienda Ospedaliera ‘Civile M.P. Arezzo’, Ragusa, Italy, 9 Dipartamento di Medicina Clinica e Sperimentale, Federico II University, Compagnia di San Paolo, Naples, Italy, 10 Department of Medicine, University Hospital Malmo, Lund University Malmo, Sweden, 11 Department of Nutritional Research, University of Umeå, Sweden, 12 Andalusian School of Public Health, Granada, Spain, 13 Department of Public Health of Guipuzkoa, San Sebastian, Spain, 14 Public Health Institute of Navarra, Pamplona, Spain, 15 Epidemiology Department, Health Council of Murcia, Spain, 16 Public Health and Health Planning Directorate, Asturias, Spain, 17 Cancer Epidemiology Unit, University of Oxford, UK, 18 Institute of Community Medicine, University of Tromso, Norway, 19 Institute of Molecular Pathology and Immunology of the University of Porto and Medical Faculty, Porto, Portugal, 20 Division of Clinical Epidemiology, Deutsches Krebsforschungszentrum, Heidelberg, Germany, 21 Department of Clinical Epidemiology, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark, 22 Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark, 23 Center for Nutrition and Health, National Institute for Public Health and the Environment, Bilthoven, The Netherlands, 24 Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, The Netherlands, 25 INSERM, Institut Gustave Roussy, Villejuif, France, 26 Department of Hygiene and Epidemiology, Medical School, University of Athens, Greece, 27 Det Sundhedsvidenskabelige Fakultet, Syddansk Universitet, Denmark, 28 Department of Medical Biosciences, University of Umea, Sweden, 29 Nutrition and Hormones Group, International Agency for Research on Cancer, Lyon, France and 30 Department of Epidemiology and Public Health, Imperial College, London, UK

* To whom correspondence and requests for reprints should be addressed at: Department of Epidemiology, Catalan Institute of Oncology (ICO-IDIBELL), Avenue Gran vía s/n km. 2.7 (08907) L'Hospitalet de Llobregat, Barcelona, Spain. Email: paujak{at}ico.scs.es

The risk of gastric cancer (GC) associated with dietary intake of nitrosodimethylamine (NDMA) and endogenous formation of nitroso compounds (NOCs) was investigated in the European Prospective Investigation into Cancer and Nutrition (EPIC). The study included 521 457 individuals and 314 incident cases of GC that had occurred after 6.6 average years of follow-up. An index of endogenous NOC (ENOC) formation was estimated using data of the iron content from meat intake and faecal apparent total NOC formation according to previous published studies. Antibodies to Helicobacter pylori and vitamin C levels were measured in a sub-sample of cases and matched controls included in a nested case–control within the cohort. Exposure to NDMA was <1 µg on average compared with 93 µg on average from ENOC. There was no association between NDMA intake and GC risk (HR, 1.00; 95% CI, 0.7–1.43). ENOC was significantly associated with non-cardia cancer risk (HR, 1.42; 95% CI, 1.14–1.78 for an increase of 40 µg/day) but not with cardia cancer (HR, 0.96; 95% CI, 0.69–1.33). Although the number of not infected cases is low, our data suggest a possible interaction between ENOC and H.pylori infection (P for interaction = 0.09). Moreover, we observed an interaction between plasma vitamin C and ENOC (P < 0.02). ENOC formation may account for our previously reported association between red and processed meat consumption and gastric cancer risk.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
MutagenesisHome page
S. Rohrmann, S.-U. Lukas Jung, J. Linseisen, and W. Pfau
Dietary intake of meat and meat-derived heterocyclic aromatic amines and their correlation with DNA adducts in female breast tissue
Mutagenesis, March 1, 2009; 24(2): 127 - 132.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. Wang and Y. Wang
Chemical synthesis of oligodeoxyribonucleotides containing N3- and O4-carboxymethylthymidine and their formation in DNA
Nucleic Acids Res., February 1, 2009; 37(2): 336 - 345.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. Shibata, S. Maeda, Y. Hikiba, A. Yanai, K. Sakamoto, H. Nakagawa, K. Ogura, M. Karin, and M. Omata
c-Jun NH2-Terminal Kinase 1 Is a Critical Regulator for the Development of Gastric Cancer in Mice
Cancer Res., July 1, 2008; 68(13): 5031 - 5039.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.